Publications by authors named "Shu-ling Zhang"

Article Synopsis
  • * Mitochondrial dysfunction in T cells leads to exhaustion, hindering their ability to fight cancer effectively.
  • * Recent strategies focus on restoring T cell function by targeting mitochondria through metabolic changes and regulation of reactive species, paving the way for new therapies in cancer immunotherapy.
View Article and Find Full Text PDF
Article Synopsis
  • The study aims to assess how effective first-line treatments using PD-(L)1 blockade are in patients with extensive-stage small-cell lung cancer (ES-SCLC), focusing on those with and without liver metastases (LM).
  • Through a network meta-analysis of seven randomized controlled trials involving 3658 patients, the study compares the outcomes of chemo-immunotherapy (CIT) and chemotherapy (CT) based on overall survival (OS) and progression-free survival (PFS).
  • Results indicate that for patients with LM, the combination of anti-PD-1 and CT is the most effective treatment, while for those without LM, the best outcomes are seen with a regimen combining anti-angiogenesis, PD-L1 blockade, and
View Article and Find Full Text PDF

Objectives: The aim of this study was to investigate the clinical benefit and necessity of neoadjuvant programmed cell death (or ligand) (PD-(L)1) blockades in resectable non-small cell lung cancer (NSCLC) patients with negative PD-L1 expression.

Materials And Methods: Randomized control trials (RCTs) that compared event-free survival (EFS), overall survival (OS), major pathological response (MPR), and/or pathological complete response (pCR) between neoadjuvant chemo-immunotherapy (nCIT) and neoadjuvant chemotherapy (nCT) for patients with resectable NSCLC stratified by PD-L1 expression were eligible for inclusion in the study. Data regarding the pathological response and EFS were evaluated by the odds ratio (OR) and hazard ratio (HR) with 95% confidence interval (CI) using random and fixed models.

View Article and Find Full Text PDF

Background: In China, Niuxi-Mugua formula (NMF) has been widely used to prevent and treat coronavirus disease 2019 (COVID-19). However, the mechanism of NMF for treating COVID-19 is not yet fully understood.

Objective: This study aimed to explore the potential mechanism of NMF for treating COVID- 19 by network pharmacology, computational biology, and surface plasmon resonance (SPR) verification.

View Article and Find Full Text PDF

Purpose: To determine the role and rational application of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) adjuvant therapy in patients with completely resected stage IB-IIIA EGFR-mutant non-small-cell lung cancer (NSCLC).

Method: Randomized controlled trials (RCTs) that compared the survival outcomes between adjuvant EGFR-TKIs and adjuvant chemotherapy or a placebo, or between different EGFR-TKI treatment durations for resected NSCLC, were eligible for inclusion. Disease-free survival (DFS) and overall survival (OS) with hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated as effective measures using random-effect or fixed-effect models.

View Article and Find Full Text PDF

Poly (ADP-ribose)-polymerases (PARPs) play an essential role in the maintenance of genome integrity, DNA repair, and apoptosis. PARP inhibitors (PARPi) exert antitumor effects via synthetic lethality and PARP trapping. PARPi impact the antitumor immune response by modulating the tumor microenvironment, and their effect has dual properties of promoting and inhibiting the antitumor immune response.

View Article and Find Full Text PDF

To investigate the effects of aerobic versus resistance exercise on soleus muscle contractile properties and the expressions of MuRF1, PGC-1α and FNDC5 in amyotrophic rats after unloading, and the possible molecular biological mechanisms. Male Wistar rats were randomly divided into recovery group (CT), aerobic exercise group (A), resistance exercise group (R) and control group (C), with 6 rats in each group. The control group did not receive any treatment.

View Article and Find Full Text PDF

Immune checkpoint and antiangiogenic inhibitors have a potentially synergistic antitumor effect. We aimed to assess the efficacy and safety of immunotherapy in combination with antiangiogenesis therapy with or without chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC). PubMed, Embase, the Cochrane library, Google Scholar, Ovid, Scopus, and Web of Science were searched for eligible trials.

View Article and Find Full Text PDF

Purpose: Epidermal growth factor receptor (EGFR) T790M-negative/unknown advanced non-small cell lung cancer (NSCLC) patients lack subsequent approved targeted therapies. This meta-analysis aimed to assess the efficacy of osimertinib in advanced NSCLC patients with different T790M status after resistance to prior first- or second-generation EGFR-tyrosine kinase inhibitors (EGFR-TKIs) and to predict the subgroups that may benefit beside T790M-positive disease.

Methods: PubMed, Embase, Web of Science, and Cochrane Library databases were searched for relevant trials.

View Article and Find Full Text PDF

Objective: Exon 19 deletion (19del) is a sensitive mutation of epidermal growth factor receptor (EGFR) observed in non-small cell lung cancer (NSCLC), and consists of a large number of variants. It remains unclear whether 19del subtype impacts clinical outcomes following EGFR tyrosine kinase inhibitor (TKI) therapy.

Methods: We systematically searched web databases and identified eligible studies comparing the clinical outcomes of various EGFR 19del subtypes with EGFR-TKIs.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the best initial treatment options for advanced non-squamous non-small cell lung cancer (NS-NSCLC), particularly for patients intolerant to immunotherapy and those experiencing progression after targeted therapies.
  • A meta-analysis was conducted, combining data from several randomized controlled trials, focusing on various treatment regimens involving bevacizumab and chemotherapy, while examining their effects on overall survival, progression-free survival, and treatment-related adverse events.
  • Results indicated that the regimen including pemetrexed-platinum combined with bevacizumab (PP ± B) improved progression-free survival compared to paclitaxel-carboplatin with bevacizumab (PC + B), although it was associated with higher rates of
View Article and Find Full Text PDF

Background: The outcomes of immediate autologous breast reconstruction (IABR) after partial mastectomy followed by postoperative radiotherapy (RT) in terms of aesthetics, treatment-related complications, and local control are unclear. In this study, we evaluated the efficacy of IABR after partial mastectomy with or without breast RT, and thus the impact of radiation on autologous flap transfer.

Method: A retrospective cohort study involving consecutive breast cancer patients who underwent IABR after partial mastectomy between July 2011 and December 2017 at Shengjing Hospital was performed.

View Article and Find Full Text PDF

To investigate the effects of Ganmai Dazao Tang on behavior and monoamine neurotransmitters in rats with depression, and to explore its potential mechanism from synaptic structure. Sixty SD rats were randomly divided into 5 groups: normal control group, model group, fluoxetine group (10.8 mg/kg), Ganmai Dazao Tang high and low dose group (9.

View Article and Find Full Text PDF

Purpose: A meta-analysis of randomized controlled trials (RCTs) was conducted to compare the difference in efficacy and safety between epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) with antiangiogenic inhibitors (A + T) and EGFR-TKI monotherapy in patients with treatment-naïve advanced EGFR-mutant non-small-cell lung cancer (NSCLC).

Methods: PubMed, Embase, Web of Science, and Cochrane electronic databases were searched for relevant RCTs. Meeting abstracts were also reviewed to identify appropriate studies.

View Article and Find Full Text PDF
Article Synopsis
  • Neoadjuvant EGFR-tyrosine kinase inhibitors (TKI) are being tested for efficacy and safety in patients with EGFR-mutant non-small cell lung cancer (NSCLC), with a pooled analysis of five clinical trials involving 124 patients.
  • Results showed a 58.5% objective response rate (ORR), with surgical resection rates at 79.9% and complete resection at 64.3%, indicating promising outcomes for treatment before surgery.
  • Despite some adverse events like skin rash and hepatotoxicity, median progression-free survival (PFS) was 13.2 months and overall survival was 41.9 months, though there were no instances of complete pathologic response in the
View Article and Find Full Text PDF

This study aimed to investigate the antidepressant effects of Puyu Capsules and its potential mechanism. The antidepressant activity of Puyu Capsules was evaluated by forced swimming test(FST) and tail suspension test(TST) after subchronic administration in mice. Next, the mice were subjected to a chronic unpredictable stress(CUS) protocol for a period of 28 d to induce depressive-like behaviors.

View Article and Find Full Text PDF

Background: This study aims to examine the effect of supportive psychological intervention (SPI) on psychological disorders (PD) in clinical medicine students (CMS) with English Learning Difficulties (ELD).

Methods: We will perform a comprehensive literature search from the following databases: Cochrane Library, MEDLINE, EMBASE, Allied and Complementary Medicine Database, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure. All databases will be performed from their inception to the present without language limitation by 2 independent reviewers.

View Article and Find Full Text PDF

Objective: To investigate the effects of modified Xiaoyao San on TLR4/NF-κB pathway in hippocampal microglia of LPS-induced depression model rats, and to explore its antidepressant mechanism.

Methods: SD rats were randomly divided into control, model, fluoxetine (10 mg·kg), low and high dose of modified Xiaoyao San (3.64, 7.

View Article and Find Full Text PDF

Purpose: To assess the efficacy and safety of recombinant human endostatin in combination with radiotherapy (RT) or concurrent chemoradiotherapy (CCRT) in patients with locally advanced non-small cell lung cancer (LA-NSCLC).

Methods: We searched eligible literature in available databases using combinations of the following search terms: lung cancer, endostatin or endostar, radiotherapy or radiation therapy or chemoradiotherapy. The inclusion criteria were: prospective or retrospective (including single-arm) studies that evaluated the efficacy and safety of endostatin plus radiotherapy (ERT) or concurrent chemoradiotherapy (ECRT) in patients with LA-NSCLC.

View Article and Find Full Text PDF

Background: This study aimed to assess the impact of pre-existing pulmonary interstitial lesions (PIL) on the efficacy and prognosis of patients with epidermal growth factor receptor (EGFR) mutant non-small cell lung cancer (NSCLC) treated with EGFR tyrosine kinase inhibitor (TKI).

Methods: Patients with advanced NSCLC harboring EGFR exon 19 deletion (E19 del) or exon 21 (E21) L858R were enrolled in this study. All patients underwent high resolution computed tomography (HRCT) chest scans prior to EGFR-TKI treatment.

View Article and Find Full Text PDF
Article Synopsis
  • * A case study of a 36-year-old man showed that after initial success with trastuzumab and chemotherapy, he developed resistance and experienced a series of treatments that included apatinib and lapatinib, but these were ultimately ineffective.
  • * The patient's condition improved with a combination of capecitabine and pyrotinib, highlighting pyrotinib's potential as a valuable option for salvage therapy in resistant HER2-positive gastric cancer cases.
View Article and Find Full Text PDF

Background: The purpose of this study was to investigate the anti-tumor activities and the mechanisms of the third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib, combined with the anti-angiogenic target drug apatinib, in the treatment of lung adenocarcinoma. We investigated the effects of these drugs in PC9 (E19 del) and H1975 (E21 L858R/E20 T790M) cell lines, as well as in both mouse and human experiments.

Methods: PC9 and H1975 cells were cultured in 96-well plates and incubated with osimertinib (1-100 nmol/L), or apatinib (100-1,000 nmol/L), or a combination of the two agents, for 48 h.

View Article and Find Full Text PDF

Background: Studies have shown that extensive genetic or spatial heterogeneity is present within tumors. The present study explored the influence of heterogeneous cells in the tumor microenvironment (TME) on the sensitivity of EGFR-mutant lung adenocarcinoma cells to EGFR-TKIs and further investigated associated molecular mechanisms.

Methods: Tumor heterogeneity was simulated using transwell co-culture technique with H1975, A549 or MRC-5 cells grown in the upper chambers and PC-9 cells cultured in the bottom chamber.

View Article and Find Full Text PDF

: Mitochondrial imbalance of division and fusion will lead to uncontrolled cell growth. This study investigated the effects of mitochondrial dynamics regulated by dynamin-related protein 1 (Drp1) on the invasion and metastasis of lung cancer cells at the cellular level. : Lentivirus-mediated RNAi and gene overexpression vectors containing shDrp1 and Lv-Drp1 were transfected into lung adenocarcinoma cell lines 95D and A549, respectively.

View Article and Find Full Text PDF